Sandoz Loses Bid For Attys' Fees In Lovenox Spat
A federal judge has shot down an attempt by generic-drug maker Sandoz Inc. to obtain attorneys' fees and costs in an infringement suit brought against it by Sanofi-Aventis units over patents...To view the full article, register now.
Already a subscriber? Click here to view full article